FS
Fletcher Spaght, Inc.
Micro VCActiveFletcher Spaght, Inc. provides strategy and financial assistance to new ventures including start-ups.
31
Investments
8
Exits
—
AUM
25.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Fletcher Spaght, Inc..
Investment Thesis & Strategy
Fletcher Spaght, Inc. invests in early-stage companies across consulting, consumer, information technology, and healthcare, providing strategic and financial support to help them grow.
Investment Activity
Deals per year over the last 6 years
1
20031
20040
20050
20061
20077
2008Portfolio Companies
Selected investments from their portfolio of 31 companies
C
Cubist Pharmaceuticals
Biotech · Series A, 0
M
Millennium Pharmaceuticals
Biotech · Series A, 0
R
Radius Health
Biotech · Series A, 2008
T
Tetraphase Pharmaceuticals
Biotech · Series A, 2008
A
Aegerion Pharmaceuticals
Biotech · Series A, 2008
E
Esperion Therapeutics
Biotech · Series A, 2008
R
Radius Health
Biotech · Series A, 2008
C
Catabasis Pharmaceuticals
Biotech · Series A, 2008
C
Catabasis Pharmaceuticals
Biotech · Series A, 2008
E
Epizyme
Biotech · Series A, 2007
P
Portola Pharmaceuticals
Biotech · Series A, 2004
A
Acceleron Pharma
Biotech · Series A, 2003
Frequently Asked Questions
Fletcher Spaght, Inc. focuses on Seed, Series A stage investments.